Alas I exited my personal position (at a modest profit) when Lonnie Mulder resigned, and so missed this big move. But it looks to me that this drug should ultimately replace Taxol (and maybe other taxanes too), and so likely the stock is still underpriced here. But it's kind of hard for me to buy back in again.
Market Data 
Markets 
AI
